PAHC logo

Phibro Animal Health (PAHC) EBITDA

annual EBITDA:

$69.06M-$36.97M(-34.86%)
June 30, 2024

Summary

  • As of today (July 1, 2025), PAHC annual EBITDA is $69.06 million, with the most recent change of -$36.97 million (-34.86%) on June 30, 2024.
  • During the last 3 years, PAHC annual EBITDA has fallen by -$41.15 million (-37.34%).
  • PAHC annual EBITDA is now -45.93% below its all-time high of $127.73 million, reached on June 30, 2018.

Performance

PAHC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPAHCincome statement metrics

quarterly EBITDA:

$51.38M+$25.81M(+100.91%)
March 1, 2025

Summary

  • As of today (July 1, 2025), PAHC quarterly EBITDA is $51.38 million, with the most recent change of +$25.81 million (+100.91%) on March 1, 2025.
  • Over the past year, PAHC quarterly EBITDA has increased by +$23.88 million (+86.83%).
  • PAHC quarterly EBITDA is now at all-time high.

Performance

PAHC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPAHCincome statement metrics

TTM EBITDA:

$125.10M+$23.88M(+23.59%)
March 1, 2025

Summary

  • As of today (July 1, 2025), PAHC TTM EBITDA is $125.10 million, with the most recent change of +$23.88 million (+23.59%) on March 1, 2025.
  • Over the past year, PAHC TTM EBITDA has increased by +$42.26 million (+51.01%).
  • PAHC TTM EBITDA is now -4.76% below its all-time high of $131.36 million, reached on September 30, 2018.

Performance

PAHC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPAHCincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

PAHC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-34.9%+86.8%+51.0%
3 y3 years-37.3%+34.4%+4.3%
5 y5 years-38.7%+68.1%+23.7%

PAHC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-41.0%at lowat high+2226.2%at high+81.5%
5 y5-year-41.0%at lowat high+2226.2%at high+81.5%
alltimeall time-45.9%+59.1%at high+1527.4%-4.8%+794.5%

PAHC EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$51.38M(+100.9%)
$125.10M(+23.6%)
Dec 2024
-
$25.58M(-4.6%)
$101.22M(+8.2%)
Sep 2024
-
$26.80M(+25.5%)
$93.53M(+35.7%)
Jun 2024
$69.06M(-34.9%)
$21.35M(-22.4%)
$68.94M(-16.8%)
Mar 2024
-
$27.50M(+53.8%)
$82.85M(-1.0%)
Dec 2023
-
$17.89M(+709.6%)
$83.65M(-7.9%)
Sep 2023
-
$2.21M(-93.7%)
$90.82M(-14.3%)
Jun 2023
$106.03M(-9.5%)
$35.25M(+24.5%)
$106.02M(+11.8%)
Mar 2023
-
$28.31M(+13.0%)
$94.81M(-9.5%)
Dec 2022
-
$25.05M(+43.8%)
$104.74M(-8.3%)
Sep 2022
-
$17.41M(-27.6%)
$114.19M(-2.5%)
Jun 2022
$117.13M(+6.3%)
$24.04M(-37.1%)
$117.13M(-2.3%)
Mar 2022
-
$38.24M(+10.9%)
$119.92M(+8.8%)
Dec 2021
-
$34.49M(+69.4%)
$110.24M(+6.9%)
Sep 2021
-
$20.36M(-24.1%)
$103.14M(-6.4%)
Jun 2021
$110.21M(+8.5%)
$26.82M(-6.1%)
$110.21M(-0.0%)
Mar 2021
-
$28.56M(+4.2%)
$110.23M(-1.8%)
Dec 2020
-
$27.40M(-0.1%)
$112.25M(-1.2%)
Sep 2020
-
$27.43M(+2.2%)
$113.61M(+12.3%)
Jun 2020
$101.58M(-9.9%)
$26.84M(-12.2%)
$101.14M(+7.3%)
Mar 2020
-
$30.57M(+6.3%)
$94.22M(+0.8%)
Dec 2019
-
$28.76M(+92.2%)
$93.45M(-1.7%)
Sep 2019
-
$14.96M(-24.9%)
$95.07M(-15.7%)
Jun 2019
$112.75M
$19.92M(-33.2%)
$112.75M(-10.5%)
Mar 2019
-
$29.81M(-1.9%)
$125.95M(-3.5%)
Dec 2018
-
$30.38M(-6.9%)
$130.57M(-0.6%)
DateAnnualQuarterlyTTM
Sep 2018
-
$32.64M(-1.5%)
$131.36M(+2.8%)
Jun 2018
$127.73M(+3.5%)
$33.12M(-3.8%)
$127.73M(+4.8%)
Mar 2018
-
$34.43M(+10.5%)
$121.90M(-2.5%)
Dec 2017
-
$31.16M(+7.4%)
$125.01M(+0.9%)
Sep 2017
-
$29.02M(+6.3%)
$123.95M(+0.4%)
Jun 2017
$123.42M(+5.6%)
$27.29M(-27.3%)
$123.42M(-1.5%)
Mar 2017
-
$37.54M(+24.7%)
$125.31M(+7.0%)
Dec 2016
-
$30.11M(+5.7%)
$117.11M(+4.1%)
Sep 2016
-
$28.48M(-2.4%)
$112.52M(-3.7%)
Jun 2016
$116.83M(+1.7%)
$29.19M(-0.5%)
$116.83M(+3.5%)
Mar 2016
-
$29.34M(+15.0%)
$112.89M(-2.2%)
Dec 2015
-
$25.51M(-22.2%)
$115.42M(-0.5%)
Sep 2015
-
$32.79M(+29.8%)
$115.99M(+0.9%)
Jun 2015
$114.92M(+88.9%)
$25.25M(-20.7%)
$114.92M(+33.5%)
Mar 2015
-
$31.86M(+22.2%)
$86.07M(+12.6%)
Dec 2014
-
$26.08M(-17.8%)
$76.44M(+6.8%)
Sep 2014
-
$31.72M(-981.2%)
$71.57M(+17.6%)
Jun 2014
$60.84M(-16.2%)
-$3.60M(-116.2%)
$60.84M(-26.3%)
Mar 2014
-
$22.23M(+4.8%)
$82.53M(+5.2%)
Dec 2013
-
$21.21M(+1.0%)
$78.42M(+10.2%)
Sep 2013
-
$20.99M(+16.0%)
$71.20M(+41.8%)
Jun 2013
$72.64M(+9.5%)
$18.09M(-0.2%)
$50.20M(+56.3%)
Mar 2013
-
$18.13M(+29.6%)
$32.11M(+129.6%)
Dec 2012
-
$13.99M
$13.99M
Jun 2012
$66.34M(+52.9%)
-
-
Jun 2011
$43.40M
-
-

FAQ

  • What is Phibro Animal Health annual EBITDA?
  • What is the all time high annual EBITDA for Phibro Animal Health?
  • What is Phibro Animal Health annual EBITDA year-on-year change?
  • What is Phibro Animal Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Phibro Animal Health?
  • What is Phibro Animal Health quarterly EBITDA year-on-year change?
  • What is Phibro Animal Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Phibro Animal Health?
  • What is Phibro Animal Health TTM EBITDA year-on-year change?

What is Phibro Animal Health annual EBITDA?

The current annual EBITDA of PAHC is $69.06M

What is the all time high annual EBITDA for Phibro Animal Health?

Phibro Animal Health all-time high annual EBITDA is $127.73M

What is Phibro Animal Health annual EBITDA year-on-year change?

Over the past year, PAHC annual EBITDA has changed by -$36.97M (-34.86%)

What is Phibro Animal Health quarterly EBITDA?

The current quarterly EBITDA of PAHC is $51.38M

What is the all time high quarterly EBITDA for Phibro Animal Health?

Phibro Animal Health all-time high quarterly EBITDA is $51.38M

What is Phibro Animal Health quarterly EBITDA year-on-year change?

Over the past year, PAHC quarterly EBITDA has changed by +$23.88M (+86.83%)

What is Phibro Animal Health TTM EBITDA?

The current TTM EBITDA of PAHC is $125.10M

What is the all time high TTM EBITDA for Phibro Animal Health?

Phibro Animal Health all-time high TTM EBITDA is $131.36M

What is Phibro Animal Health TTM EBITDA year-on-year change?

Over the past year, PAHC TTM EBITDA has changed by +$42.26M (+51.01%)
On this page